Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.1.1 Initial data exploration
1.1.2 Statistical model and forecast
1.1.3 Industry insights and validation
1.1.4 Definitions & forecast parameters
1.2 Data sources
1.2.1 Secondary
1.2.2 Primary
Chapter 2 Executive Summary
2.1 Eye health ingredients market 3600 synopsis, 2018 –2032
2.1.1 Business trends
2.1.2 Source trends
2.1.3 Ingredient trends
2.1.4 Form trends
2.1.5 Application trends
2.1.6 Disease indication trends
2.1.7 Regional trends
Chapter 3 Eye Health Ingredients Industry Insights
3.1 Industry segmentation
3.2 Industry growth landscape, 2018 –2032
3.3 Industry ecosystem analysis
3.3.1 Regional profit margin trends
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 APAC
3.3.1.4 LATAM
3.3.1.5 MEA
3.3.2 Vendor matrix
3.3.2.1 Raw material suppliers
3.3.2.2 Ingredient manufacturers
3.3.2.3 Geographical footprint
3.3.2.4 Production capacity of key players
3.3.3 Distribution channel analysis
3.3.3.1 Supermarkets
3.3.3.2 Specialty retail
3.3.3.3 Pharmacy Chains
3.3.3.4 Independent Retailers
3.3.3.5 Internet/ home shopping
3.4 Regional pricing trends
3.4.1 North America
3.4.2 Europe
3.4.3 APAC
3.4.4 LATAM
3.4.5 MEA
3.5 Trade scenario
3.6 Regulatory landscape
3.6.1 Regulation of Color Additives
3.6.1.1 U.S.
3.6.1.2 Europe
3.6.1.3 China
3.6.1.4 APAC
3.7 Regional raw material trends
3.7.1 Lutein
3.7.2 Zeaxanthin
3.7.3 Beta Carotene
3.7.4 Vitamin A
3.7.5 Bilberry extracts
3.7.6 Others (Capsanthin, Annatto, Omega-3)
3.8 Industry impact forces
3.8.1 Growth drivers
3.8.1.1 Increasing consumer concerns around eye health
3.8.1.2 Nutraceutical industry expansion
3.8.1.3 Increasing AMD disease occurrence among geriatric population
3.8.1.4 Increase in healthcare expenditure leading consumer interest over OTC supplements
3.8.2 Industry pitfalls & challenges
3.8.2.1 Limited availability of lutein and zeaxanthin
3.8.2.2 Harmful health effects from carotenoid consumption
3.9 Eye health ingredients latest product launches
3.9.1 U.S.
3.9.2 Germany
3.9.3 Russia
3.9.4 India
3.9.5 UK
3.9.6 China
3.9.7 Brazil
3.9.8 South Africa
3.10 Growth potential analysis, 2022
3.11 Critical success factors
3.11.1 Role of industry associations
3.11.2 International demographics of declining vision
3.11.3 Consumer behavior towards eye health ingredients
3.11.4 OTC eye care supplements vs prescribed eyecare supplements
3.11.5 Regional consumer insights
3.11.5.1 North America
3.11.5.2 Europe
3.11.5.3 APAC
3.11.5.4 LATAM
3.11.5.5 MEA
3.12 Porter's analysis
3.13 Company market share analysis, 2022
3.13.1 Strategy dashboard
3.14 PESTEL analysis
Chapter 4 Eye Health Ingredients Market, By Source
4.1 Global eye health ingredients market share by source, 2018 & 2032
4.2 Natural
4.2.1 Market estimates and forecast, 2018 –2032
4.2.2 Market estimates and forecast, by region, 2018–2032
4.3 Synthetic
4.3.1 Market estimates and forecast, 2018 –2032
4.3.2 Market estimates and forecast, by region, 2018–2032
Chapter 5 Eye Health Ingredients Market, By Ingredient
5.1 Global eye health ingredients market share by ingredient, 2018 & 2032
5.2 Lutein
5.2.1 Market estimates and forecast, 2018 –2032
5.2.2 Market estimates and forecast, by region, 2018–2032
5.3 Zeaxanthin
5.3.1 Market estimates and forecast, 2018 –2032
5.3.2 Market estimates and forecast, by region, 2018–2032
5.4 Beta Carotene
5.4.1 Market estimates and forecast, 2018 –2032
5.4.2 Market estimates and forecast, by region, 2018–2032
5.5 Vitamin A
5.5.1 Market estimates and forecast, 2018 –2032
5.5.2 Market estimates and forecast, by region, 2018–2032
5.6 Bilberry extracts
5.6.1 Market estimates and forecast, 2018 –2032
5.6.2 Market estimates and forecast, by region, 2018–2032
5.7 Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)
5.7.1 Market estimates and forecast, 2018 –2032
5.7.2 Market estimates and forecast, by region, 2018–2032
Chapter 6 Eye Health Ingredients Market, By Form
6.1 Global eye health ingredients market share by form, 2018 & 2032
6.2 Soft gel, capsule & tablets
6.2.1 Market estimates and forecast, 2018 –2032
6.2.2 Market estimates and forecast, by region, 2018–2032
6.3 Liquid
6.3.1 Market estimates and forecast, 2018 –2032
6.3.2 Market estimates and forecast, by region, 2018–2032
6.4 Powder
6.4.1 Market estimates and forecast, 2018 –2032
6.4.2 Market estimates and forecast, by region, 2018–2032
Chapter 7 Eye Health Ingredients Market, By Application
7.1 Global eye health ingredients market share by application, 2018 & 2032
7.2 Human
7.2.1 Market estimates and forecast, 2018 –2032
7.2.2 Market estimates and forecast, by region, 2018–2032
7.3 Animal
7.3.1 Market estimates and forecast, 2018 –2032
7.3.2 Market estimates and forecast, by region, 2018–2032
Chapter 8 Eye Health Ingredients Market, By Disease Indication
8.1 Global eye health ingredients market share by disease indication, 2018 & 2032
8.2 Age related macular degeneration
8.2.1 Market estimates and forecast, 2018 –2032
8.2.2 Market estimates and forecast, by region, 2018–2032
8.3 Cataract
8.3.1 Market estimates and forecast, 2018 –2032
8.3.2 Market estimates and forecast, by region, 2018–2032
8.4 Dry eye syndrome
8.4.1 Market estimates and forecast, 2018 –2032
8.4.2 Market estimates and forecast, by region, 2018–2032
8.5 Other indications
8.5.1 Market estimates and forecast, 2018 –2032
8.5.2 Market estimates and forecast, by region, 2018–2032
Chapter 9 Eye Health Ingredients Market, By Region
9.1 Global eye health ingredients market share by region, 2018 & 2032
9.2 North America
9.2.1 Market estimates and forecast, 2018 – 2032
9.2.2 Market estimates and forecast, by source, 2018 – 2032
9.2.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.2.4 Market estimates and forecast, by form, 2018 – 2032
9.2.5 Market estimates and forecast, by application, 2018 – 2032
9.2.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.2.7 U.S.
9.2.7.1 Market estimates and forecast, 2018 – 2032
9.2.7.2 Market estimates and forecast, by source, 2018 – 2032
9.2.7.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.2.7.4 Market estimates and forecast, by form, 2018 – 2032
9.2.7.5 Market estimates and forecast, by application, 2018 – 2032
9.2.7.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.2.8 Canada
9.2.8.1 Market estimates and forecast, 2018 – 2032
9.2.8.2 Market estimates and forecast, by source, 2018 – 2032
9.2.8.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.2.8.4 Market estimates and forecast, by form, 2018 – 2032
9.2.8.5 Market estimates and forecast, by application, 2018 – 2032
9.2.8.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3 Europe
9.3.1 Market estimates and forecast, 2018 – 2032
9.3.2 Market estimates and forecast, by source, 2018 – 2032
9.3.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.4 Market estimates and forecast, by form, 2018 – 2032
9.3.5 Market estimates and forecast, by application, 2018 – 2032
9.3.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3.7 Germany
9.3.7.1 Market estimates and forecast, 2018 – 2032
9.3.7.2 Market estimates and forecast, by source, 2018 – 2032
9.3.7.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.7.4 Market estimates and forecast, by form, 2018 – 2032
9.3.7.5 Market estimates and forecast, by application, 2018 – 2032
9.3.7.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3.8 UK
9.3.8.1 Market estimates and forecast, 2018 – 2032
9.3.8.2 Market estimates and forecast, by source, 2018 – 2032
9.3.8.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.8.4 Market estimates and forecast, by form, 2018 – 2032
9.3.8.5 Market estimates and forecast, by application, 2018 – 2032
9.3.8.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3.9 France
9.3.9.1 Market estimates and forecast, 2018 – 2032
9.3.9.2 Market estimates and forecast, by source, 2018 – 2032
9.3.9.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.9.4 Market estimates and forecast, by form, 2018 – 2032
9.3.9.5 Market estimates and forecast, by application, 2018 – 2032
9.3.9.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3.10 Italy
9.3.10.1 Market estimates and forecast, 2018 – 2032
9.3.10.2 Market estimates and forecast, by source, 2018 – 2032
9.3.10.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.10.4 Market estimates and forecast, by form, 2018 – 2032
9.3.10.5 Market estimates and forecast, by application, 2018 – 2032
9.3.10.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.3.11 Russia
9.3.11.1 Market estimates and forecast, 2018 – 2032
9.3.11.2 Market estimates and forecast, by source, 2018 – 2032
9.3.11.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.3.11.4 Market estimates and forecast, by form, 2018 – 2032
9.3.11.5 Market estimates and forecast, by application, 2018 – 2032
9.3.11.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.4 Asia Pacific
9.4.1 Market estimates and forecast, 2018 – 2032
9.4.2 Market estimates and forecast, by source, 2018 – 2032
9.4.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.4.4 Market estimates and forecast, by form, 2018 – 2032
9.4.5 Market estimates and forecast, by application, 2018 – 2032
9.4.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.4.7 China
9.4.7.1 Market estimates and forecast, 2018 – 2032
9.4.7.2 Market estimates and forecast, by source, 2018 – 2032
9.4.7.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.4.7.4 Market estimates and forecast, by form, 2018 – 2032
9.4.7.5 Market estimates and forecast, by application, 2018 – 2032
9.4.7.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.4.8 India
9.4.8.1 Market estimates and forecast, 2018 – 2032
9.4.8.2 Market estimates and forecast, by source, 2018 – 2032
9.4.8.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.4.8.4 Market estimates and forecast, by form, 2018 – 2032
9.4.8.5 Market estimates and forecast, by application, 2018 – 2032
9.4.8.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.4.9 South Korea
9.4.9.1 Market estimates and forecast, 2018 – 2032
9.4.9.2 Market estimates and forecast, by source, 2018 – 2032
9.4.9.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.4.9.4 Market estimates and forecast, by form, 2018 – 2032
9.4.9.5 Market estimates and forecast, by application, 2018 – 2032
9.4.9.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.4.10 Japan
9.4.10.1 Market estimates and forecast, 2018 – 2032
9.4.10.2 Market estimates and forecast, by source, 2018 – 2032
9.4.10.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.4.10.4 Market estimates and forecast, by form, 2018 – 2032
9.4.10.5 Market estimates and forecast, by application, 2018 – 2032
9.4.10.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.5 Latin America
9.5.1 Market estimates and forecast, 2018 – 2032
9.5.2 Market estimates and forecast, by source, 2018 – 2032
9.5.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.5.4 Market estimates and forecast, by form, 2018 – 2032
9.5.5 Market estimates and forecast, by application, 2018 – 2032
9.5.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.5.7 Brazil
9.5.7.1 Market estimates and forecast, 2018 – 2032
9.5.7.2 Market estimates and forecast, by source, 2018 – 2032
9.5.7.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.5.7.4 Market estimates and forecast, by form, 2018 – 2032
9.5.7.5 Market estimates and forecast, by application, 2018 – 2032
9.5.7.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.5.8 Mexico
9.5.8.1 Market estimates and forecast, 2018 – 2032
9.5.8.2 Market estimates and forecast, by source, 2018 – 2032
9.5.8.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.5.8.4 Market estimates and forecast, by form, 2018 – 2032
9.5.8.5 Market estimates and forecast, by application, 2018 – 2032
9.5.8.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.5.9 Argentina
9.5.9.1 Market estimates and forecast, 2018 – 2032
9.5.9.2 Market estimates and forecast, by source, 2018 – 2032
9.5.9.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.5.9.4 Market estimates and forecast, by form, 2018 – 2032
9.5.9.5 Market estimates and forecast, by application, 2018 – 2032
9.5.9.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.6 Middle East & Africa (MEA)
9.6.1 Market estimates and forecast, 2018 – 2032
9.6.2 Market estimates and forecast, by source, 2018 – 2032
9.6.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.6.4 Market estimates and forecast, by form, 2018 – 2032
9.6.5 Market estimates and forecast, by application, 2018 – 2032
9.6.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.6.7 Saudi Arabia
9.6.7.1 Market estimates and forecast, 2018 – 2032
9.6.7.2 Market estimates and forecast, by source, 2018 – 2032
9.6.7.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.6.7.4 Market estimates and forecast, by form, 2018 – 2032
9.6.7.5 Market estimates and forecast, by application, 2018 – 2032
9.6.7.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.6.8 UAE
9.6.8.1 Market estimates and forecast, 2018 – 2032
9.6.8.2 Market estimates and forecast, by source, 2018 – 2032
9.6.8.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.6.8.4 Market estimates and forecast, by form, 2018 – 2032
9.6.8.5 Market estimates and forecast, by application, 2018 – 2032
9.6.8.6 Market estimates and forecast, by disease indication, 2018 – 2032
9.6.9 South Africa
9.6.9.1 Market estimates and forecast, 2018 – 2032
9.6.9.2 Market estimates and forecast, by source, 2018 – 2032
9.6.9.3 Market estimates and forecast, by ingredient, 2018 – 2032
9.6.9.4 Market estimates and forecast, by form, 2018 – 2032
9.6.9.5 Market estimates and forecast, by application, 2018 – 2032
9.6.9.6 Market estimates and forecast, by disease indication, 2018 – 2032
Chapter 10 Company Profiles
10.1 Allied Biotech Corporation
10.1.1 Business Overview
10.1.2 Financial Data
10.1.3 Concentrations Landscape
10.1.4 Strategic Outlook
10.1.5 SWOT Analysis
10.2 BASF
10.2.1 Business Overview
10.2.2 Financial Data
10.2.3 Concentrations Landscape
10.2.4 Strategic Outlook
10.2.5 SWOT Analysis
10.3 DSM
10.3.1 Business Overview
10.3.2 Financial Data
10.3.3 Concentrations Landscape
10.3.4 Strategic Outlook
10.3.5 SWOT Analysis
10.4 Kemin
10.4.1 Business Overview
10.4.2 Financial Data
10.4.3 Concentrations Landscape
10.4.4 Strategic Outlook
10.4.5 SWOT Analysis
10.5 Tianjin Pharmaland Technology
10.5.1 Business Overview
10.5.2 Financial Data
10.5.3 Concentrations Landscape
10.5.4 Strategic Outlook
10.5.5 SWOT Analysis
10.6 American River Nutrition, Inc
10.6.1 Business Overview
10.6.2 Financial Data
10.6.3 Concentrations Landscape
10.6.4 Strategic Outlook
10.6.5 SWOT Analysis
10.7 Archer Daniels Midland Company
10.7.1 Business Overview
10.7.2 Financial Data
10.7.3 Concentrations Landscape
10.7.4 Strategic Outlook
10.7.5 SWOT Analysis
10.8 Vitae Naturals
10.8.1 Business Overview
10.8.2 Financial Data
10.8.3 Concentrations Landscape
10.8.4 Strategic Outlook
10.8.5 SWOT Analysis
10.9 Davos life Science
10.9.1 Business Overview
10.9.2 Financial Data
10.9.3 Concentrations Landscape
10.9.4 Strategic Outlook
10.9.5 SWOT Analysis
10.10 Cargil
10.10.1 Business Overview
10.10.2 Financial Data
10.10.3 Concentrations Landscape
10.10.4 Strategic Outlook
10.10.5 SWOT Analysis
10.11 Wilmer Spring Fruit Nutrition Products Co. Ltd
10.11.1 Business Overview
10.11.2 Financial Data
10.11.3 Concentrations Landscape
10.11.4 Strategic Outlook
10.11.5 SWOT Analysis
10.12 FMC corporation
10.12.1 Business Overview
10.12.2 Financial Data
10.12.3 Concentrations Landscape
10.12.4 Strategic Outlook
10.12.5 SWOT Analysis
10.13 Vidya Europe SAS
10.13.1 Business Overview
10.13.2 Financial Data
10.13.3 Concentrations Landscape
10.13.4 Strategic Outlook
10.13.5 SWOT Analysis
Chapter 11 Potential Customer Profiles
11.1 Amway
11.1.1 Business Overview
11.1.2 Financial Data
11.1.3 Concentrations Landscape
11.1.4 Strategic Outlook
11.2 Solgar
11.2.1 Business Overview
11.2.2 Financial Data
11.2.3 Concentrations Landscape
11.2.4 Strategic Outlook
11.3 Life extension
11.3.1 Business Overview
11.3.2 Financial Data
11.3.3 Concentrations Landscape
11.3.4 Strategic Outlook
11.4 Jarrow Formulas
11.4.1 Business Overview
11.4.2 Financial Data
11.4.3 Concentrations Landscape
11.4.4 Strategic Outlook
11.5 NOW Foods
11.5.1 Business Overview
11.5.2 Financial Data
11.5.3 Concentrations Landscape
11.5.4 Strategic Outlook
11.6 Natures’s Life
11.6.1 Business Overview
11.6.2 Financial Data
11.6.3 Concentrations Landscape
11.6.4 Strategic Outlook
11.7 Nutrovea
11.7.1 Business Overview
11.7.2 Financial Data
11.7.3 Concentrations Landscape
11.7.4 Strategic Outlook
11.8 Natures Lab
11.8.1 Business Overview
11.8.2 Financial Data
11.8.3 Concentrations Landscape
11.8.4 Strategic Outlook
11.9 Zenith Nutrition
11.9.1 Business Overview
11.9.2 Financial Data
11.9.3 Concentrations Landscape
11.9.4 Strategic Outlook
11.10 Blubonnet Nutrition
11.10.1 Business Overview
11.10.2 Financial Data
11.10.3 Concentrations Landscape
11.10.4 Strategic Outlook
11.11 Sirulina
11.11.1 Business Overview
11.11.2 Financial Data
11.11.3 Concentrations Landscape
11.11.4 Strategic Outlook
11.12 Caps Extra
11.12.1 Business Overview
11.12.2 Financial Data
11.12.3 Concentrations Landscape
11.12.4 Strategic Outlook
11.13 MacuShield
11.13.1 Business Overview
11.13.2 Financial Data
11.13.3 Concentrations Landscape
11.13.4 Strategic Outlook
11.14 PreserVision
11.14.1 Business Overview
11.14.2 Financial Data
11.14.3 Concentrations Landscape
11.14.4 Strategic Outlook
11.15 Efalex
11.15.1 Business Overview
11.15.2 Financial Data
11.15.3 Concentrations Landscape
11.15.4 Strategic Outlook
11.16 BioCare NutriGuard
11.16.1 Business Overview
11.16.2 Financial Data
11.16.3 Concentrations Landscape
11.16.4 Strategic Outlook
11.17 Futurebiotics
11.17.1 Business Overview
11.17.2 Financial Data
11.17.3 Concentrations Landscape
11.17.4 Strategic Outlook
11.18 Swanson Products
11.18.1 Business Overview
11.18.2 Financial Data
11.18.3 Concentrations Landscape
11.18.4 Strategic Outlook
11.19 Davis Vision
11.19.1 Business Overview
11.19.2 Financial Data
11.19.3 Concentrations Landscape
11.19.4 Strategic Outlook
11.20 Alcon
11.20.1 Business Overview
11.20.2 Financial Data
11.20.3 Concentrations Landscape
11.20.4 Strategic Outlook
11.21 Pfizer Inc.
11.21.1 Business Overview
11.21.2 Financial Data
11.21.3 Concentrations Landscape
11.21.4 Strategic Outlook
11.22 Vitabiotics Ltd.
11.22.1 Business Overview
11.22.2 Financial Data
11.22.3 Concentrations Landscape
11.22.4 Strategic Outlook
11.23 Valeant Pharmaceuticals International Inc.
11.23.1 Business Overview
11.23.2 Financial Data
11.23.3 Concentrations Landscape
11.23.4 Strategic Outlook
11.24 Alliance Pharma
11.24.1 Business Overview
11.24.2 Financial Data
11.24.3 Concentrations Landscape
11.24.4 Strategic Outlook
11.25 The Nature's Bounty Co
11.25.1 Business Overview
11.25.2 Financial Data
11.25.3 Concentrations Landscape
11.25.4 Strategic Outlook
11.26 Novartis AG
11.26.1 Business Overview
11.26.2 Financial Data
11.26.3 Concentrations Landscape
11.26.4 Strategic Outlook
